Bruce Mixan
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Toxin Mechanisms and Immunotoxins 6
- Co-authors
- Alan F. Wahl (6 shared papers)Clay B. Siegall (11 shared papers)Dana F. Chace (9 shared papers)Peter D. Senter (4 shared papers)Kerry Klussman (4 shared papers)Charles G. Cerveny (4 shared papers)Kristine A. Gordon (3 shared papers)Che‐Leung Law (3 shared papers)
- Journals
- Bioconjugate Chemistry (4 papers)The Journal of Immunology (2 papers)Clinical Cancer Research (1 paper)Journal of Biological Chemistry (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Bruce Mixan
14 papers receiving 1.1k citations
Bruce Mixan's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 608
- Radiology, Nuclear Medicine and Imaging 489
- Biotechnology 162
- Pathology and Forensic Medicine 285
- Immunology 286
Countries citing papers authored by Bruce Mixan
This map shows the geographic impact of Bruce Mixan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Mixan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Mixan more than expected).
Fields of papers citing papers by Bruce Mixan
This network shows the impact of papers produced by Bruce Mixan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Mixan. The network helps show where Bruce Mixan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce Mixan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity Hit paper breakdown → | 2003 | 668 |
| 2 | 2005 | 99 | |
| 3 | 2004 | 84 | |
| 4 | 2001 | 80 | |
| 5 | 1997 | 41 | |
| 6 | 1994 | 36 | |
| 7 | Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs. | 1997 | 36 |
| 8 | 2001 | 30 | |
| 9 | 1997 | 26 | |
| 10 | 1994 | 20 | |
| 11 | 1995 | 20 | |
| 12 | 2004 | 17 | |
| 13 | 1995 | 10 | |
| 14 | 1998 | 7 |
About Bruce Mixan
Bruce Mixan is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Molecular Biology and Biotechnology, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Toxin Mechanisms and Immunotoxins (6 papers), HER2/EGFR in Cancer Research (4 papers), Transgenic Plants and Applications (3 papers), Bacteriophages and microbial interactions (2 papers), Glycosylation and Glycoproteins Research (2 papers), Microtubule and mitosis dynamics (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (608 citations), Radiology, Nuclear Medicine and Imaging (489 citations), Biotechnology (162 citations), Pathology and Forensic Medicine (285 citations) and Immunology (286 citations). Bruce Mixan has collaborated with scholars based in United States and Germany. Frequent co-authors include Alan F. Wahl, Clay B. Siegall, Dana F. Chace, Peter D. Senter, Kerry Klussman, Charles G. Cerveny, Kristine A. Gordon, Che‐Leung Law, Joseph A. Francisco and Damon L. Meyer. Their work appears in journals such as Bioconjugate Chemistry, The Journal of Immunology, Clinical Cancer Research, Journal of Biological Chemistry and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.